產品分類

    Products

    產品中心/ PRODUCTS

    我的位置:首頁  >  產品中心  >    >  動物活體成像設備  >  腫瘤測量儀

    腫瘤測量儀

    • 更新時間:2024-10-11
    • 訪  問  量:891

    簡要描述:動物腫瘤測量儀,非常適合對大鼠小鼠等動物的皮下腫瘤進行快速測量、分析,精確測量動物腫瘤并對腫瘤信息存檔與跟蹤

    在線咨詢

    聯系電話:021-54377179

    產品詳情

    動物腫瘤測量儀,非常適合對大鼠小鼠等動物的皮下腫瘤進行快速測量、分析,精確測量動物腫瘤并對腫瘤信息存檔與跟蹤。


    主要技術參數: 

    · 測量范圍:0-25mm腫瘤尺寸:20*20*20mm
    · 3D測量精確度:<0.3mm
    · 圖像捕捉時間:0.1s
    · 接口:USB 2.0
    · 相機:1600*1200 像素(2MP)
    · 工作距離:50mm


    動物腫瘤測量分析儀的主要特點: 
    · 手持式成像裝置,實現立體成像;
    · 適合測量不同尺寸的腫瘤;
    · 方便使用:觸屏式電腦,操作方便;
    · 內置軟件,自動計算腫瘤尺寸,跟蹤整個實驗進展。 
      

    · 快速,高效,保證了高通量和可靠測量;
    · 全自動測量跟蹤系統;
    · 實時數據分析與處理。 


         
      
     


    部分用戶: 

    Hunter College, CUNY

    Vanderbilt University Medical Center

    Hainan Medical University

    Howard Hughes Medical Institute

    Memorial Sloan Kettering Cancer Center

    Cancer Center Amsterdam

    GlaxoSmithKline

    Imec

    K.U.Leuven

    Neuro-Electronics Research Flanders

    Pepric

    PharmaVize

    reMYND

    University Ghent

    SEPS Pharma

    Vlaams Instituut voor Biotechnologie

    University Antwerp

    ThromboGenics

    Janssen Pharmaceutica

    City University of Hong Kong


    參考文獻:

    1.Adams EJ, Karthaus WR, Hoover E, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571(7765):408-412. doi:10.1038/s41586-019-1318-9.
    2.Zhang Z, Zhou C, Li X, et al. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. Cancer Cell. 2020;37(4):584-598.e11. doi:10.1016/j.ccell.2020.03.001.
    3.Santich BH, Park JA, Tran H, et al. Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies. Sci Transl Med. 2020;12(534):eaax1315. doi:10.1126/scitranslmed.aax1315.
    4.Park JA, Xu H, Cheung, I, et al. Abstract B38: Tetravalent bispecific antibodies specific for HER2 and disialoganglioside GD2 to engage polyclonal T cells for osteosarcoma therapy. Cancer Res. 2018;78(19),B38.doi:10.1158/1538-7445.PEDCA17-B38.
    5.Wu CF, Wu CY, Lin CF, et al. The anticancer effects of cyanidin 3-O-glucoside combined with 5-fluorouracil on lung large-cell carcinoma in nude mice. Biomed Pharmacother. 2022;151:113128. doi:10.1016/j.biopha.2022.113128.
    6.Wang L, Hoseini SS, Xu H, et al. Silencing Fc Domains in T cell-Engaging Bispecific Antibodies Improves T-cell Trafficking and Antitumor Potency. Cancer Immunol Res. 2019;7(12):2013-2024. doi:10.1158/2326-6066.CIR-19-0121.
    7.Grochowska A, Statkiewicz M, Kulecka M, et al. Evidence supporting the oncogenic role of BAZ1B in colorectal cancer. Am J Cancer Res. 2022;12(10):4751-4763. 
    8.Hoseini SS, Vadlamudi M, Espinosa-Cotton M, et al. T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. J Immunother Cancer. 2021;9(5):e002509. doi:10.1136/jitc-2021-002509.
    9.Beguin E, Gray MD, Logan KA, et al. Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device. J Control Release. 2020;317:23-33. doi:10.1016/j.jconrel.2019.11.013.
    10.Mao N, Gao D, Hu W, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18(9):1577-1586. doi:10.1158/1535-7163.MCT-18-1386.
    11.Wu Z, Guo HF, Xu H, et al. Development of a Tetravalent Anti-GPA33/Anti-CD3 Bispecific Antibody for Colorectal Cancers. Mol Cancer Ther. 2018;17(10):2164-2175. doi:10.1158/1535-7163.MCT-18-0026.
    12.Poty S, Mandleywala K, O'Neill E, et al. 89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma. Theranostics. 2020;10(13):5802-5814. doi:10.7150/thno.44772.
    13.Hoseini SS, Guo H, Wu Z, et al. A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia. Blood Adv. 2018;2(11):1250-1258. doi:10.1182/bloodadvances.2017014373.
    14.Zhang Z, Karthaus WR, Lee YS, et al. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer. Cancer Cell. 2020;38(2):279-296.e9. doi:10.1016/j.ccell.2020.06.005.
    15.Poty S, Carter LM, Mandleywala K, et al. Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2019;25(2):868-880. doi:10.1158/1078-0432.CCR-18-1650.




        

        

        :,

             

        :

        yuyanbio

        :yuyanbio

        

    在線咨詢

    留言框

    • 產品:

    • 您的單位:

    • 您的姓名:

    • 聯系電話:

    • 常用郵箱:

    • 省份:

    • 詳細地址:

    • 補充說明:

    • 驗證碼:

      請輸入計算結果(填寫阿拉伯數字),如:三加四=7
    上海玉研科學儀器有限公司
    地址:上海市閔行區興梅路485號眾欣大廈506室
    郵箱:sales@yuyanbio.com
    傳真:021-35183767
    掃一掃關注我們
    SCAN
    久久精品国产亚洲麻豆| 99久久国产综合精品成人影院| 影视网欧洲精品| 国产精品一区二区av不卡| 久热精品视频第一页| 亚洲日韩一页精品发布| 97久久国产亚洲精品超碰热| 97精品国产97久久久久久免费| 欧美国产精品久久高清| 亚洲av无码乱码国产精品| 国产精品久久国产精麻豆99网站| 精品国产91久久久久久久a| 欧美丝袜激情办公室在线观看| 欧洲精品色在线观看| 久久久久免费精品国产| 久久久久国产日韩精品网站| 午夜精品久久久久久久| 97久视频精品视频在线老司机| 亚洲第一区精品日韩在线播放| 日韩av无码久久精品免费| 国产L精品国产亚洲区久久 | 98香蕉草草视频在线精品看| 无码AⅤ精品一区二区三区| 精品无码一区二区三区爱欲 | 午夜福利麻豆国产精品| 国产精品一久久香蕉国产线看观看| 久久精品人人做人人爽电影| 亚洲AV无码成人精品区狼人影院| 精品欧洲av无码一区二区| 精品国产不卡一区二区三区 | 精品久久777| 亚洲成人国产精品| 国产精品免费网站| 亚洲欧美国产∧v精品综合网| 国产成人久久精品一区二区三区 | 亚洲欧美日韩国产精品影院| 99久久精品国产免看国产一区| 欧美激情精品久久久久久久| 国产精品高清一区二区三区| 青青青青久久精品国产h久久精品五福影院1421| 无码精品A∨在线观看中文|